124 related articles for article (PubMed ID: 1735343)
1. Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies.
Anderson RP; Butt TJ; Chadwick VS
Dig Dis Sci; 1992 Feb; 37(2):248-56. PubMed ID: 1735343
[TBL] [Abstract][Full Text] [Related]
2. Radio-immunoassay for formyl methionyl leucyl phenylalanine. II. Demonstration of an enterohepatic circulation of immunoreactive bacterial chemotactic peptides in man.
Roberts EC; Hobson CH; Anderson RP; Chadwick VS
J Gastroenterol Hepatol; 1990; 5(1):38-43. PubMed ID: 2103382
[TBL] [Abstract][Full Text] [Related]
3. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis.
Hobson CH; Butt TJ; Ferry DM; Hunter J; Chadwick VS; Broom MF
Gastroenterology; 1988 Apr; 94(4):1006-13. PubMed ID: 3345870
[TBL] [Abstract][Full Text] [Related]
4. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Showell HJ; Freer RJ; Becker EL
J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
[TBL] [Abstract][Full Text] [Related]
6. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier.
Ferry DM; Butt TJ; Broom MF; Hunter J; Chadwick VS
Gastroenterology; 1989 Jul; 97(1):61-7. PubMed ID: 2498147
[TBL] [Abstract][Full Text] [Related]
7. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
[TBL] [Abstract][Full Text] [Related]
8. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Becker EL
J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of enzymes involved in the degradation of chemotactic N-formyl peptides.
Nguyen KT; Pei D
Biochemistry; 2005 Jun; 44(23):8514-22. PubMed ID: 15938642
[TBL] [Abstract][Full Text] [Related]
11. Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria.
Hobson CH; Roberts EC; Broom MF; Mellor DM; Sherriff RM; Chadwick VS
J Gastroenterol Hepatol; 1990; 5(1):32-7. PubMed ID: 2129421
[TBL] [Abstract][Full Text] [Related]
12. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of biliary lipid from bile acid secretion by formyl-methionyl-leucyl-phenylalanine in the rat.
Mizuno K; Hoshino M; Hayakawa T; Yamada H; Nakazawa T; Inagaki T; Takeuchi T; Kunimatsu M
Hepatology; 1996 Nov; 24(5):1224-9. PubMed ID: 8903402
[TBL] [Abstract][Full Text] [Related]
14. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
15. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
Bonora GM; Toniolo C; Freer RJ; Becker EL
Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
[TBL] [Abstract][Full Text] [Related]
16. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
Kermode JC; Muthukumaraswamy N; Freer RJ
J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
[TBL] [Abstract][Full Text] [Related]
18. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
Beswick PH; Kay AB
Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
[TBL] [Abstract][Full Text] [Related]
19. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Fantone JC; Freer RJ; Ward PA
Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
